Laurus Labs Ltd.

Financial

	Laurus Labs	Neuland Laboratories	Granules India
Operational Metrics
API Sector
US DMF Filings	87.0 .	69.0 .	39.0 .
Pharmaceutical Sector
Number of ANDA's Filed in Europe	18.0	n/a	n/a
Number of ANDA's Approved in Europe	15.0	n/a	n/a
Number of ANDA's Filed in USA	42.0 .	n/a	83.0 .
Number of ANDA's Approved By USFDA	35.0 .	n/a	66.0 .
Number of ANDA's Approved by Canada	15.0	n/a	n/a
Number of ANDA's Filed in Canada	22.0	n/a	n/a
R&D as a % of Total Sales	5.4 %	2.79 %	3.15 %
Financials
5 yr Average ROE	20.05 %	11.99 %	18.04 %
5yr average Equity Multiplier	2.06	1.62	1.73
5yr Average Asset Turnover Ratio	0.74	0.72	0.85
5yr Avg Net Profit Margin	12.47 %	10.09 %	12.26 %
Price to Book	7.29	12.78	4.19
P/E	229.98	63.77	29.46
5yr Avg Cash Conversion Cycle	109.81 Days	45.08 Days	39.26 Days
Inventory Days	110.32 Days	89.03 Days	75.67 Days
Days Receivable	117.42 Days	86.1 Days	78.34 Days
Days Payable	143.67 Days	113.14 Days	115.94 Days
5yr Average Interest Coverage Ratio	9.19	12.92	18.0
5yr Avg ROCE	24.17 %	16.09 %	22.1 %
5yr Avg Operating Profit Margin	24.55 %	19.31 %	21.01 %
5 yr average Debt to Equity	0.56	0.21	0.41
5yr CAGR Net Profit	-9.19 %	79.26 %	3.86 %
5yr Average Return on Assets	9.61 %	7.75 %	10.46 %
Shareholdings
Promoter Holding	27.18 %	32.64 %	38.87 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.12 %	-3.58 %	-3.17 %
Change in Mutual Fund Holding (3 Yrs)	6.17 %	3.25 %	5.29 %

Business

	Laurus Labs	Neuland Laboratories	Granules India
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 46.0 Formulations 27.0 Synthesis 24.0 Bio 3.0 Ingredients 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 MCB 0 GGF 0 IBU ( Ibuprofen) 0 MF(Metformin) 0 Para 0	Product Wise Break-Up Formulations 0 Bio 0 Para 0 MCB 0 Active Pharmaceutical Ingredient (API) 0 IBU ( Ibuprofen) 0 Ingredients 0 GGF 0 MF(Metformin) 0 Custom Manufacturing Solutions(CMS) 42.0 Formulations 52.0 Synthesis 0 Others 6.0	Product Wise Break-Up Formulations 0 Bio 0 Paracetamol 46.0 MCB 3.0 Active Pharmaceutical Ingredient (API) 0 Ibuprofen 10.0 Ingredients 0 GGF 4.0 Metformin 22.0 Custom Manufacturing Solutions(CMS) 0 Generic Drug Substances(GDS) 0 Synthesis 0 Others 15.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 56.0 Europe 27.0 North America 17.0 India 0 USA 0 Canada 0 AMEA 0 Latin America 0	Location Wise Break-Up Europe 30.51 India 19.51 Latin America 0 Rest of the World 10.44 Canada 0 USA 39.54 North America 0 AMEA 0	Location Wise Break-Up Europe 10.0 India 2.0 Latin America 4.0 Rest of the World 5.0 Canada 0 USA 79.0 North America 0 AMEA 0